Osteoporosis redux

Journal of Nuclear Medicine

Volumn 47, Issue 12, 2006, Pages 1945-1959

  Lentle, Brian ^a   Worsley, Daniel ^b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; SALCATONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE; VITAMIN D;

ABSORPTIOMETRY; BONE NECROSIS; BONE RADIOGRAPHY; BONE TURNOVER; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; DUAL PHOTON ABSORPTIOMETRY; ECHOGRAPHY; FRAGILITY FRACTURE; HUMAN; HYPERCALCEMIA; LIFESTYLE MODIFICATION; MUSCLE CRAMP; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE ENERGY PHOTON ABSORPTIOMETRY; SINGLE ENERGY X RAY ABSORPTIOMETRY; VERTEBRA FRACTURE; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; FEMALE; METHODOLOGY; PATHOLOGIC FRACTURE; POSTMENOPAUSE; PRACTICE GUIDELINE;

DIAGNOSTIC IMAGING; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS; POSTMENOPAUSE; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS;

EID: 35148853679     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (138)

1. NIH Consensus Statement. Osteoporosis prevention, diagnosis, and therapy. Available at: http://odp.od.nih.gov/consensus/cons/111/111_statement.pdf. Accessed April 25, 2006.
2. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1991;90:170-210.
3. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1994. WHO technical report series 0512-3054; 843.
4. Looker AC, Johnston CC Jr, Wahner HW, et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res. 1995;10:796-802.
5. Compston JE, Cooper C, Kanis JA. Bone densitometry in clinical practice. Br Med J. 1995;310:1507-1510.
6. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int. 1997;7:390-406.
7. Eddy DM, Johnston CC, Cummings SR, et al. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int. 1998;8(suppl):S1-S88.
8. www.ISCD.org. Accessed April 10, 2006.
9. Hadler NM. The Last Well Person: How to Stay Well Despite the Health Care System. Montreal, Quebec, Canada: McGill-Queen's University Press; 2004:146-165.
10. Graham R, Russell G, Espina B, Hulley P. Bone biology and the pathogenesis of osteoporosis. Curr Opin Rheumatol. 2006;18(suppl 1):S3-S10.
11. Sackett DL, Haynes RB, Guyatt GH, Tuwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, MA: Little Brown and Co.; 1991:168.
12. Gehlbach SH, Bigelow C, Heimisdottir M, et al. Recognition of vertebral fractures in a clinical setting. Osteoporos Int. 2000;11:577-582.
13. Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi J. The osteoporosis care gap in Canada. Available at: http://www.biomedcentral.com/ info/authors. Accessed May 21, 2006.
14. Port L, Center J, Briffa NK, Nguyen T, Cumming R, Eisman J. Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int. 2003;9:780-784.
15. Matkovic V, Goel PK, Badenhop-Stevens NE, et al. Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial. Am J Clin Nutr. 2005;81:175-188.
16. Heaney RP, Matkovic V. Inadequate peak bone mass. In: Riggs BL, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis and Management. Philadelphia, PA: Lippincott-Raven; 1995:115.
17. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81:341-354.
18. Rodan GA, Rodan SB. The cells of bone. In: Riggs BZ, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis and Management. Philadelphia, PA: Lippincott-Raven; 1995:1-39.
19. Delmas PD. Biochemical markers for the assessment of bone turnover. In: Riggs BZ, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis and Management. Philadelphia, PA: Lippincott-Raven; 1995: 319-333.
20. Grampp S, Genant HK, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing age related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12:697-711.
21. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone density predict occurrence of osteoporotic fractures. Br Med J. 1996;312:1254-1259.
22. Johnston CC Jr, Melton LJ III. Bone densitometry. In: Riggs BL, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis and Management. Philadelphia, PA: Lippincott-Raven; 1995:275.
23. Bonnick SL. Bone Densitometry in Clinical Practice. Philadelphia, PA: Lippincott-Raven; 1995:1.
24. Blake GM, Glüer C-C, Fogelman I. Bone densitometry: current status and future prospects. Br J Radiol. 1997;70(suppl):S177-S186.
25. Blake GM, Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med. 1997;27:210-228.
26. Webber CE. Photon absorptiometry, bone densitometry and the challenge of osteoporosis. Phys Med Biol. 2006;51:R169-R185.
27. Baim S, Wilson CR, Lewiecki EM, Luckey MM, Downs RW Jr, Lentle BC. Precision assessment and radiation safety for dual-energy x-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom. 2005;8:371-378.
28. Bonnick SL. Bone Densitometry in Clinical Practice. Philadelphia, PA: Lippincott-Raven; 1995:257-263.
29. Link TM, Koppers BB, Licht T, Bauer J, Lu Y, Rummeny EJ. In vitro and in vivo spiral CT to determine bone mineral density: initial experience in patients at risk for osteoporosis. Radiology. 2004;231:805-811.
30. Cann CE, Genant HK. Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr. 1980;4:493-500.
31. Lang TF, Guglielmi G, van Kuijk C, De Serio A, Cammisa M, Genant HK. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy x-ray absorptiometry in elderly women with and without vertebral fractures. Bone. 2002;30:247-250.
32. Ito M, Ikeda K, Nishiguchi M, et al. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J Bone Miner Res. 2005;20:1828-1836.
33. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by high resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90:6508-6515.
34. Lieb E, Lewiecki EM, Binkley N, Hamdy RC. Official positions of the International Society for Clinical Densitometry. J Clin Densitom. 2004;7:1-5.
35. Miller PD, Bonnick SL, Johnston CC. The challenges of peripheral bone density testing. J Clin Densitom. 1998;1:211-217.
36. Black DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res. 1992;7:633-638.
37. Gluer C-C, Jergas M, Hans D. Peripheral measurement techniques for the assessment of osteoporosis. Semin Nucl Med. 1997;27:229-247.
38. Njeh CF, Hans D, Fuerst T, Gluer C-C, Genant HK. Quantitative ultrasound: assessment of osteoporosis and bone status. London, U.K.: Martin Dunitz; 1999.
39. Nayak S, Olkin I, Liu H, et al. Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med. 2006;144:832-841.
40. Vokes TJ, Favus MJ. Non-invasive assessment of bone structure. Curr Osteoporos Rep. 2003;1:20-24.
41. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:19-23.
42. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-739.
43. Fink HA, Ensrud KE, Nelson DB, et al. Disability after clinical fracture in postmenopausal women with low bone density: the Fracture Intervention Trial (FIT). Osteoporos Int. 2003;14:69-76.
44. Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M, Kirkwood JR. Recognition of vertebral fractures in a clinical setting. Osteoporos Int. 2000;11:577-582.
45. Kim N, Rowe BH, Raymond G, et al. Underreporting of vertebral fractures on routine chest radiography. AJR. 2004;182:297-300.
46. Majumdar SR, Kim N, Colman I, et al. Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med. 2005;165:905-909.
47. National Osteoporosis Foundation Working Group on Vertebral Fractures. Assessing vertebral fractures. J Bone Miner Res. 1995;10:518-523.
48. Delmas PD, van de Langerijt L, Watts NB, et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT Study. J Bone Miner Res. 2005;20:557-563.
49. International Osteoporosis Foundation and European Society of Musculoskeletal Radiology. Vertebral Fracture Initiative. Available at: http://www.osteofound.org/health_professionals/vfi/index-flash.html. Accessed October 3, 2006.
50. Link TM, Guglielmi G, van Kuijk C, Adams JE. Radiologic assessment of osteoporotic fractures: diagnostic and prognostic implications. Eur Radiol. 2005;15:1521-1532.
51. Lentle BC, Brown J, Khan A, et al. The recognition and reporting of vertebral fractures: a powerful tool to reduce the risk of future fractures. J Can Assoc Radiol. In press.
52. Ferrar L, Jiang G, Eastell R, Peel NF. Visual identification of vertebral fractures in osteoporosis using morphometric x-ray absorptiometry. J Bone Miner Res. 2003;18:933-938.
53. Blake GM, Rea JA, Fogelman I. Vertebral morphometry studies using dualenergy x-ray absorptiometry. Semin Nucl Med. 1997;27:276-290.
54. Genant HK, Wu Cy, Van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-1148.
55. Jiang G, Eastell R, Barrington NA, Ferrar L. Comparison of methods for the visual identification of vertebral fractures. Osteoporos Int. 2004;15:887-896.
56. Ferrar L, Jiang G, Adams J, Eastell R. Identification of vertebral fractures: an update. Osteoporos Int. 2005;16:717-728.
57. Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J. 2000;163:819-822.
58. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002;162:2217-2222.
59. Onder G, Pedone C, Gambassi G, Landi F, Cesari M, Bernabei R. Treatment of osteoporosis among older adults discharged from hospital in Italy. Eur J Clin Pharmacol. 2001;57:599-604.
60. Juby AG, Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int. 2002;13:205-210.
61. Simonelli C, Chen YT, Morancey J, Leis AF, Abbott TA. Evaluation and management of osteoporosis following hospitalization for low-impact fracture. J Gen Intern Med. 2003;18:17-22.
62. Gardner MJ, Flik KR, Mooar P, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am. 2002;85-A:1342-1348.
63. Parker M, Johansen A. Hip fracture: clinical review. Br Med J. 2006;333:27-30.
64. http://www.osteoporosis.ca/english/News/newmodel/default. Accessed July 2006.
65. Black D, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12:519-528.
66. Siminoski K, Leslie WD, Frame H, et al. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J. 2005;56:178-188.
67. Verschueren SM, Roelants M, Delecluse C, Swinnen S, Vanderschueren D, Boonen S. Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J Bone Miner Res. 2004;19:352-359.
68. O'Loughlin JL, Robitaille Y, Boivin JF, Suissa S. Incidence of and risk factors for falls and injurious falls among the community dwelling elderly. Am J Epidemiol. 1993;137:342-354.
69. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev. 2003;4:CD000340.
70. Parker MJ, Gillespie WJ, Gillespie LD. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev. 2005;3:CD001255.
71. Bettica P, Bevilacqua M, Vago T, Norbiato G. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int. 1999;9:226-229.
72. Guzel R, Kozanoglu E, Guyler-Uysal F, Soyupak S, Sarpel T. Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med. 2001;10:765-770.
73. Chapuy M-C, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol Metab. 1996;81:1129-1133.
74. Chapuy M-C, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. Br Med J. 1994;308:1081-1082.
75. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005;10:94-111.
76. Felson DT, Kiel DP, Anderson JJ, Kannel WB. Alcohol consumption and hip fractures: the Framingham Study. Am J Epidemiol. 1988;128:1102-1110.
77. McClung M. Bisphosphonates. Endocrinol Metab Clin North Am. 2003;32:253-271.
78. Liberman UA, Weiss SR, Broll JL. Effect of alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437-1443.
79. Reginster J, Minne HW, Sorenson OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000;11:83-91.
80. Chesnut CH III, Skag A, Christiansen C, et al. Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE): effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19:1241-1249.
81. Pun KK, Chan LW. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther. 1989;11:205-209.
82. Chesnut CH III, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. PROOF Study Group. Am J Med. 2000;109:267-276.
83. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-1441.
84. Cauley JA, Robbins J, Chen Z, for the Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative Randomized Trial. JAMA. 2003;290:1729-1738.
85. Ettinger B, Black DM, Mitlack BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637-645.
86. Cauley JA, Norton L, Lippman ME, et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE Trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Breast Cancer Res Treat. 2001;65:125-134.
87. Barrett-Connor E, Grady D, Sashegyi A, et al.; MORE Investigators (Multiple Outcomes of Raloxifene Evaluation). Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial. JAMA. 2002;287:847-857.
88. Marie PJ. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol. 2006;18(suppl 1):S11-S15.
89. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350:459-468.
90. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab. 2005;90:2816-2822.
91. McClung M, Lewiecki EM, Cohen SB, et al.; AMG 162 Bone Loss Study Group. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354:821-831.
92. Woo S-B, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-761.
93. Ensrud KE, Barrett-Connor EL, Schwartz A, for the Fracture Intervention Trial Long-Term Extension Research Group. Randomized trial of the effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial Long-Term Extension. J Bone Miner Res. 2004;19:1259-1269.
94. Hodsman AB, Hanley DA, Josse R. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. Can Med Assoc J. 2002;166:1426-1430.
95. Meunier PJ. Evidence-based medicine and osteoporosis: a comparison of fracture risk reduction data from osteoporosis randomized clinical trials. Int J Clin Pract. 1999;53:122-129.
96. www.osteofound.org/publications/position_papers_guidelines.html. Accessed June 22, 2006.
97. Bonnick SL. Bone Densitometry in Clinical Practice. Philadelphia, PA: Lippincott-Raven; 1995:361.
98. Kanis JA, Seeman E, Johnell O, Rizzoli R, Delmas P. The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry. J Clin Densitometry. 2005;8:145-147.
99. Lewiecki EM, Miller PD, Leib ES, Bilzekian JP. Response to "The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry," by John A. Kanis et al. J Clin Densitometry. 2005;8:143-144.
100. Bacon WE, Maggi S, Looker A, et al. International comparison of hip fracture rates in 1988-1989. Osteoporos Int. 1996;6:69-75.
101. Johnell O, Gullberg B, Allander E, Kanis JA. The apparent incidence of hip fracture in Europe: a study of national register sources. MEDOS Study Group. Osteoporos Int. 1992;2:298-302.
102. www.aace.com/pub/pdf/guidelines/osteoporosis2001Revised.pdf. Accessed June 26, 2006.
103. ACOG Committee Opinion. Bone density screening for osteoporosis. Int J Gynaecol Obstet. 2002;77:299-301.
104. Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S; the Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J. 2004;170:1665-1667.
105. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int. 1997;7:390-406.
106. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002;359:2018-2026.
107. The North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause. 2006;13:340-367.
108. Sturtridge W, Lentle B, Hanley DA. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. The use of bone densitometry measurement in the diagnosis of and management of osteoporosis. Can Med Assoc J. 1996;155:924-929.
109. Brown JP, Josse RG, and the Scientific Advisory Council of Osteoporosis Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J. 2002;167(suppl):S1-S34.
110. http://osteofound.org/health_professionals/fracture_risk_assessment/ index.html. Accessed May 1, 2006.
111. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women. Ann Intern Med. 2002;137:526-528.
112. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10:259-264.
113. Cranney A, Waldegger L, Graham ID, Man-Son-Hing M, Byszewski A, Ooi DS. Systematic assessment of the quality of osteoporosis guidelines. BMC Musculoskelet Disord. 2002;3:20.
114. Fuleihan Gel-H, Baddoura R, Awada H, Okais J, Rizk P, McClung M. Lebanese guidelines for osteoporosis assessment and treatment: Who to test? What measures to use? When to treat? J Clin Densitom. 2005;8:148-163.
115. Lau L, ed. Imaging Guidelines. 4th ed. Sidney, Australia: The Royal Australian and New Zealand College of Radiologists; 2001:220-221.
116. Khosla S, Melton J. Secondary osteoporosis. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, Diagnosis and Management. Philadelphia, PA: Lippincott-Raven; 1995:183-204.
117. Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974;291:1041-1046.
118. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest. 1976;58:529-534.
119. Franklyn JA, Betteridge J, Daykin J. Long term thyroxine treatment and bone mineral density. Lancet. 1992;340:9-13.
120. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab. 1994;78:818-823.
121. WHO Statement on Hormonal Contraception and Bone Health, July 2005. Available at: http://www.who.int/reproductive-health/family_planning/ docs/hormonal_contraception_bone_health.pdf. Accessed October 3, 2006.
122. Lunt M, Felsenberg D, Reeve J, et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res. 1997;12:1883-1894.
123. Weinstein RS, Bell NH. Diminished rates of bone formation in normal black adults. N Engl J Med. 1988;319:1698-1701.
124. Ross PD, He Y, Yates AJ, et al. Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group. Calcif Tissue Int. 1996;59:339-343.
125. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20:185-194.
126. Cauley JA, Lui LY, Ensrud KE, et al. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA. 2005;293:2102-2108.
127. Hadler NM. The Last Well Person: How to Stay Well Despite the Health Care System. Montreal, Quebec, Canada: McGill-Queen's University Press; 2004:37.
128. Leslie WD, Lentle B. Race/ethnicity and fracture risk assessment: an issue that's more than skin deep. J Clin Densitom. In press.
129. Garraway WM, Stauffer RN, Kurland LT, O'Fallon WM. Limb fractures in a defined population. I. Frequency and distribution. Mayo Clin Proc. 1979;54:701-707.
130. Jackson SA, Tenenhouse A, Robertson L, and the CAMOS Research Group. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int. 2000;11:680-687.
131. Fujiwara S, Mizuno S, Ochi Y, et al. Incidence of Thoracic Vertebral Fractures Among Adult Health Study Participants, Hiroshima and Nagasaki, 1958-86. Hiroshima City, Japan: Radiation Effects Research Foundation; 1990. RERF Technical Report No. 12-89.
132. Orwoll E. Perspective: assessing bone density in men. J Bone Miner Res. 2000;15:1867-1870.
133. Seeman E. From density to structure: growing up and growing old on the surfaces of bone. J Bone Miner Res. 1997;12:509-521.
134. De Laet CEDH, Van Hout Ba, Burger H, Weel AE, Hofman A, Pols HA. Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res. 1998;13:1587-1593.
135. Stewart A, Felsenberg D, Kaladis L, Reid DM. Vertebral fractures in men and women: how discriminative are bone mass measurements? Br J Radiol. 1995;68:614-620.
136. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878-882.
137. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis in men. Ann Intern Med. 1995;123:452-460.
138. U.S. Department of Health and Human Services. The 2004 Surgeon General's Report on Bone Health and Osteoporosis: What It Means to You. Available at: www.surgeongeneral.gov/library/bonehealth/docs/ OsteoBrochure1mar05.pdf. Accessed October 3, 2006.